Apogee Therapeutics, Inc. (APGE)

Apogee Therapeutics Statistics

Total Valuation

APGE has a market cap or net worth of $2.20 billion. The enterprise value is $1.59 billion.

Market Cap	2.20B
Enterprise Value	1.59B

Important Dates

The next estimated earnings date is Tuesday, November 11, 2025, before market open.

Earnings Date	Nov 11, 2025
Ex-Dividend Date	n/a

Share Statistics

APGE has 58.57 million shares outstanding. The number of shares has increased by 17.27% in one year.

Current Share Class	45.08M
Shares Outstanding	58.57M
Shares Change (YoY)	+17.27%
Shares Change (QoQ)	+0.40%
Owned by Insiders (%)	2.13%
Owned by Institutions (%)	86.81%
Float	37.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.56
P/TBV Ratio	3.56
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 16.36, with a Debt / Equity ratio of 0.02.

Current Ratio	16.36
Quick Ratio	16.15
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -34.12% and return on invested capital (ROIC) is -24.04%.

Return on Equity (ROE)	-34.12%
Return on Assets (ROA)	-23.21%
Return on Invested Capital (ROIC)	-24.04%
Return on Capital Employed (ROCE)	-43.25%
Revenue Per Employee	n/a
Profits Per Employee	-$1.21M
Employee Count	196
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, APGE has paid $173,000 in taxes.

Income Tax	173,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -26.93% in the last 52 weeks. The beta is 1.43, so APGE's price volatility has been higher than the market average.

Beta (5Y)	1.43
52-Week Price Change	-26.93%
50-Day Moving Average	37.74
200-Day Moving Average	39.28
Relative Strength Index (RSI)	50.77
Average Volume (20 Days)	487,687

Short Selling Information

The latest short interest is 9.20 million, so 15.71% of the outstanding shares have been sold short.

Short Interest	9.20M
Short Previous Month	9.12M
Short % of Shares Out	15.71%
Short % of Float	24.36%
Short Ratio (days to cover)	17.88

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-270.83M
Pretax Income	-103.55M
Net Income	-237.67M
EBITDA	-270.10M
EBIT	-270.83M
Earnings Per Share (EPS)	-$4.12

Balance Sheet

The company has $505.42 million in cash and $10.85 million in debt, giving a net cash position of $610.34 million or $10.42 per share.

Cash & Cash Equivalents	505.42M
Total Debt	10.85M
Net Cash	610.34M
Net Cash Per Share	$10.42
Equity (Book Value)	619.40M
Book Value Per Share	10.58
Working Capital	484.57M

Cash Flow

In the last 12 months, operating cash flow was -$220.74 million and capital expenditures -$5.84 million, giving a free cash flow of -$226.58 million.

Operating Cash Flow	-220.74M
Capital Expenditures	-5.84M
Free Cash Flow	-226.58M
FCF Per Share	-$3.87

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

APGE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.27%
Shareholder Yield	-17.27%
Earnings Yield	-10.78%
FCF Yield	-10.28%

Analyst Forecast

The average price target for APGE is $95.40, which is 153.52% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$95.40
Price Target Difference	153.52%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	10.99%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1